Patents by Inventor Bingzhen Lin

Bingzhen Lin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Conversion of apoptotic proteins
    Patent number: 8273705
    Abstract: Compounds that modulate the function of anti-apoptotic proteins such as Bcl-2 and Bcl-XL are identified. These compounds have the ability to convert the activity of Bcl-2-family member proteins from anti-apoptotic to pro-apoptotic. Methods for inducing apoptosis are described, together with methods for identifying molecules that induce apoptosis through interaction with Bcl-2-family members.
    Type: Grant
    Filed: February 2, 2009
    Date of Patent: September 25, 2012
    Assignee: The Burnham Institute
    Inventors: John C. Reed, Xiao-kun Zhang, Bin Guo, Bingzhen Lin, Siva Kumar Kolluri
  • CONVERSION OF APOPTOTIC PROTEINS
    Publication number: 20090215984
    Abstract: Compounds that modulate the function of anti-apoptotic proteins such as Bcl-2 and Bcl-XL are identified. These compounds have the ability to convert the activity of Bcl-2-family member proteins from anti-apoptotic to pro-apoptotic. Methods for inducing apoptosis are described, together with methods for identifying molecules that induce apoptosis through interaction with Bcl-2-family members.
    Type: Application
    Filed: February 2, 2009
    Publication date: August 27, 2009
    Applicant: The Burnham Institute
    Inventors: John C. Reed, Xiao-kun Zhang, Bin Guo, Bingzhen Lin, Siva Kumar Kolluri
  • Conversion of apoptotic proteins
    Patent number: 7491700
    Abstract: Compounds that modulate the function of anti-apoptotic proteins such as Bcl-2 and Bcl-XL are identified. These compounds have the ability to convert the activity of Bcl-2-family member proteins from anti-apoptotic to pro-apoptotic. Methods for inducing apoptosis are described, together with methods for identifying molecules that induce apoptosis through interaction with Bcl-2-family members.
    Type: Grant
    Filed: January 4, 2007
    Date of Patent: February 17, 2009
    Assignee: The Burnham Institute
    Inventors: John C. Reed, Xiao-kun Zhang, Bin Guo, Bingzhen Lin, Siva Kumar Kolluri
  • CONVERSION OF APOPTOTIC PROTEINS
    Publication number: 20070117753
    Abstract: Compounds that modulate the function of anti-apoptotic proteins such as Bcl-2 and Bcl-XL are identified. These compounds have the ability to convert the activity of Bcl-2-family member proteins from anti-apoptotic to pro-apoptotic. Methods for inducing apoptosis are described, together with methods for identifying molecules that induce apoptosis through interaction with Bcl-2-family members.
    Type: Application
    Filed: January 4, 2007
    Publication date: May 24, 2007
    Applicant: The Burnham Institute
    Inventors: John Reed, Xiao-kun Zhang, Bin Guo, Bingzhen Lin, Siva Kolluri
  • Conversion of apoptotic proteins
    Patent number: 7176277
    Abstract: Compounds that modulate the function of anti-apoptotic proteins such as Bcl-2 and Bcl-XL are identified. These compounds have the ability to convert the activity of Bcl-2-family member proteins from anti-apoptotic to pro-apoptotic. Methods for inducing apoptosis are described, together with methods for identifying molecules that induce apoptosis through interaction with Bcl-2-family members.
    Type: Grant
    Filed: October 7, 2005
    Date of Patent: February 13, 2007
    Assignee: The Burnham Institute
    Inventors: John C. Reed, Xiao-kun Zhang, Bin Guo, Bingzhen Lin, Siva Kumar Kolluri
  • Conversion of apoptotic proteins
    Publication number: 20060193864
    Abstract: Compounds that modulate the function of anti-apoptotic proteins such as Bcl-2 and Bcl-XL are identified. These compounds have the ability to convert the activity of Bcl-2-family member proteins from anti-apoptotic to pro-apoptotic. Methods for inducing apoptosis are described, together with methods for identifying molecules that induce apoptosis through interaction with Bcl-2-family members.
    Type: Application
    Filed: October 7, 2005
    Publication date: August 31, 2006
    Inventors: John Reed, Xiao-kun Zhang, Bin Guo, Bingzhen Lin, Siva Kolluri
  • Conversion of apoptotic proteins
    Patent number: 6994979
    Abstract: Compounds that modulate the function of anti-apoptotic proteins such as Bcl-2 and Bcl-XL are identified. These compounds have the ability to convert the activity of Bcl-2-family member proteins from anti-apoptotic to pro-apoptotic. Methods for inducing apoptosis are described, together with methods for identifying molecules that induce apoptosis through interaction with Bcl-2-family members.
    Type: Grant
    Filed: December 11, 2003
    Date of Patent: February 7, 2006
    Assignee: The Burnham Institute
    Inventors: John C. Reed, Xiao-kun Zhang, Bin Guo, Bingzhen Lin, Siva Kumar Kolluri
  • Conversion of apoptotic proteins
    Publication number: 20040220097
    Abstract: Compounds that modulate the function of anti-apoptotic proteins such as Bcl-2 and Bcl-XL are identified. These compounds have the ability to convert the activity of Bcl-2-family member proteins from anti-apoptotic to pro-apoptotic. Methods for inducing apoptosis are described, together with methods for identifying molecules that induce apoptosis through interaction with Bcl-2-family members.
    Type: Application
    Filed: December 11, 2003
    Publication date: November 4, 2004
    Inventors: John C. Reed, Xiao-kun Zhang, Bin Guo, Bingzhen Lin, Siva Kumar Kolluri